Showing results (1-10 of 97) with videos related to
Sort By:
Pageof 10
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 20, 2010
[Molecular target drug for hypertension and cardiovascular disease]Toshio NishikimiNihon Rinsho. Japanese Journal of Clinical Medicine|May 25, 2012
[Clinical significance of BNP as a biomarker for cardiac disease--from a viewpoint of basic science and clinical aspect]Toshio NishikimiCurrent Medicinal Chemistry|June 23, 2007
Adrenomedullin in the kidney-renal physiological and pathophysiological rolesToshio NishikimiBiology|September 14, 2022
B-Type Natriuretic Peptide (BNP) Revisited-Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?Toshio Nishikimi, Yasuaki NakagawaJournal of Pharmacological Sciences|January 7, 2006
Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosisToshio Nishikimi, Hiroaki MatsuokaBiology|February 25, 2022
Cardiac Peptides-Current Physiology, Pathophysiology, Biochemistry, Molecular Biology, and Clinical ApplicationToshio Nishikimi, Johji KatoCurrent Medicinal Chemistry. Cardiovascular and Hematological Agents|June 25, 2005
Cardiac adrenomedullin: its role in cardiac hypertrophy and heart failureToshio Nishikimi, Hiroaki MatsuokaHeart Failure Clinics|November 21, 2017
Adrenomedullin as a Biomarker of Heart FailureToshio Nishikimi, Yasuaki NakagawaJournal of Cardiology|June 5, 2021
Potential pitfalls when interpreting plasma BNP levels in heart failure practiceToshio Nishikimi, Yasuaki NakagawaBiology|September 14, 2022
CNP, the Third Natriuretic Peptide: Its Biology and Significance to the Cardiovascular SystemYasuaki Nakagawa, Toshio NishikimiPageof 10